Temporary increases in HIV levels in patients under treatment generally do not mean the virus is developing resistance to drugs, US research finds.they were more likely to be a statistical quirk.
Concern about the blips have led to costly repeat testing, and in some cases alterations in therapy, which have now been shown probably to have been unnecessary.
Lead researcher Dr Robert Siliciano said: “These results should provide relief to hundreds of thousands of HIV-positive patients currently taking drug therapy, called highly active anti-retroviral therapy, or HAART, and reassure them that their medications have not failed
The researchers have calculated that unless the blip is higher than 200 copies per millilitre of blood, or persists upon repeated testing, it does not signal that the virus has mutated, and that the drugs are losing their effectread more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment